“…The non-classical nucleation behaviour described here for Aβ42 fibril formation is analogous to the two-step nucleation processes observed in crystallisation, bio-mineralisation and sickle-cell haemoglobin. 26,27,[34][35][36][37][38][39] Moreover, we have established the absence, in our system, of detectable quantities of persistent off-pathway oligomers that cannot convert to fibrils over the timescale of aggregation, although such species may exist under different experimental conditions or for other, particularly larger, amyloidogenic proteins such as α-synuclein. 40 More generally, our work could be extended to study oligomer dynamics in peptide mixtures; in the presence of additional inhibitors, 41 11 these experiments could inform upon the role of off-pathway oligomers in such systems.…”